Uncategorized Archive

Lifetime risks are the probabilities of progressing to Alzheimer’s disease (AD) dementia during one’s lifespan. Here, we report the first estimates of the lifetime and ten-year risks of AD dementia based on age, gender, and biomarker tests for preclinical disease. Read & Research Alzheimer’s More

Be the first to comment

Both polymorphisms and mutations in glucocerebrosidase (GBA) may influence the development of dementia in patients with Parkinson’s disease. Read & Research Alzheimer’s More

Be the first to comment

Genome-wide association studies consistently show that single nucleotide polymorphisms (SNPs) in the complement receptor 1 (CR1) gene modestly but significantly alter Alzheimer’s disease (AD) risk. Follow-up research has assumed that CR1 is expressed in the human brain despite a paucity of evidence for its function there. Alternatively, erythrocytes contain >80% Read & Research Alzheimer’s More

Be the first to comment

Although the apolipoprotein E ε4-allele (APOE-ε4) is a susceptibility factor for Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB), its relationship with imaging and cognitive measures across the AD/DLB spectrum remains unexplored. Read & Research Alzheimer’s More

Be the first to comment

In March, a $414 million increase for Alzheimer’s disease (AD) and dementia research funding at the National Institutes of Health and Kevin and Avonte’s Law, important legislation to protect those who wander, were signed into law. Read & Research Alzheimer’s More

Be the first to comment

A landmark study sheds light on the underlying mechanisms that impact neural health in Parkinson’s disease and dementia. Can it lead to better treatments? Read & Research Alzheimer’s More

Be the first to comment

The interplay between midlife vascular risk factors and midlife cognitive function with later life mild cognitive impairment (MCI) and dementia (DEM) is not well understood. Read & Research Alzheimer’s More

Be the first to comment

According to the latest study, cholesterol plays a role in the formation of plaques in Alzheimer’s disease. The findings open new avenues for drug design. Read & Research Alzheimer’s More

Be the first to comment

Using machine learning techniques, researchers reveal new dementia risks. They conclude that marital status, BMI, and sleep may all play a role. Read & Research Alzheimer’s More

Be the first to comment

Recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies and clinical trials limit the development of new treatments. Widespread Internet use allows data capture from participants in an unsupervised setting. The Brain Health Registry, a website and online registry, collects data from participants and their study partners. Read & Research Alzheimer’s More

Be the first to comment

As we grow older, we find it harder to stay focused, perhaps due to changes in the brain’s attention hub. Could this also drive the onset of Alzheimer’s? Read & Research Alzheimer’s More

Be the first to comment

We conducted Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI) and compared the basic characteristics and progression profiles with those of ADNI in North America. Read & Research Alzheimer’s More

Be the first to comment

A study that followed more than 350,000 veterans found a raised risk of dementia in those who had had TBI — even mild TBI without loss of consciousness. Read & Research Alzheimer’s More

Be the first to comment

Researchers have found a small molecule that can block the spread of the toxic protein tau, a hallmark of Alzheimer’s progression. Read & Research Alzheimer’s More

Be the first to comment

Healthy physiological systems exhibit fractal regulation (FR), generating similar fluctuation patterns in physiological outputs across different time scales. FR in motor activity is degraded in dementia, and the degradation correlates to cognitive decline. We tested whether degraded FR predicts Alzheimer’s disease dementia. Read & Research Alzheimer’s More

Be the first to comment

Editorial Board"> Editorial Board

Posted May 4, 2018 By

Read & Research Alzheimer’s More

Be the first to comment

Contents"> Contents

Posted May 3, 2018 By

Read & Research Alzheimer’s More

Be the first to comment

Read & Research Alzheimer’s More

Be the first to comment

New research suggests that moderate to severe anxiety in midlife may be an independent risk factor for developing dementia in old age. Read & Research Alzheimer’s More

Be the first to comment

Alzheimer’s disease can cause people living with it to experience severe anxiety as they try to navigate an unfamiliar world. Can music help them to cope? Read & Research Alzheimer’s More

Be the first to comment

A new study links long-term anticholinergic use for depression, Parkinson’s, and loss of bladder control to raised risk of dementia up to 20 years later. Read & Research Alzheimer’s More

Be the first to comment

Recognizing dementia in general hospitals allows for tailored care. We aimed to assess hospital dementia diagnosis accuracy, changes over time, and predictors of correct identification. Read & Research Alzheimer’s More

Be the first to comment

The aim of this study was to investigate the association between acetylcholinesterase inhibitor (AChEI) use and risk of ischemic stroke and death in people with dementia. Read & Research Alzheimer’s More

Be the first to comment

The first population study of sense of smell and cognitive performance by age suggests that testing sense of smell could be a marker for cognitive decline. Read & Research Alzheimer’s More

Be the first to comment

Recognizing dementia in general hospitals allows for tailored care. We aimed to assess hospital dementia diagnosis accuracy, changes over time, and predictors of correct identification. Read & Research Alzheimer’s More

Be the first to comment

We know that eating fish protects brain health. A new study identifies the protein responsible for this and explains how it fights ‘Parkinson’s protein.’ Read & Research Alzheimer’s More

Be the first to comment

">

Posted April 21, 2018 By

Described by poet Carl Sandburg as the “City of Big Shoulders,” Chicago will host a big conference July 22-26: the Alzheimer’s Association International Conference® 2018 (AAIC®). AAIC is the world’s largest gathering of Alzheimer’s and dementia researchers, drawing more than 5,000 attendees from over 70 countries in 2017. Register now Read & Research Alzheimer’s More

Be the first to comment

We investigated brain demyelination in aging, mild cognitive impairment (MCI), and dementia using magnetic resonance imaging of myelin. Read & Research Alzheimer’s More

Be the first to comment

In June 2017, a diverse group of experts in Alzheimer’s disease convened to discuss how to accelerate getting new drugs to patients to both prevent and treat the disease. Participants concluded that we need a more robust, diversified drug development pipeline. Strategic policy measures can help keep new Alzheimer’s disease Read & Research Alzheimer’s More

Be the first to comment

Changes in glucose levels may represent a powerful metabolic indicator of dementia in African-Americans with diabetes. It is unclear whether these changes also occur in Caucasians. Read & Research Alzheimer’s More

Be the first to comment